Table 2.
Univariate and multivariate Cox regression analysis for predicting OS of PUC
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| HR | 95%CI | p value | HR | 95%CI | p value | |
| Age | ||||||
| <70 | Ref | Ref | ||||
| ≥ 70 | 1.906 | 1.667–2.179 | <0.001* | 1.948 | 1.693–2.242 | <0.001* |
| Sex | ||||||
| Male | Ref | |||||
| Female | 0.919 | 0.803–1.051 | 0.281 | |||
| Race | ||||||
| White | Ref | |||||
| Black | 1.102 | 0.937–1.297 | 0.241 | |||
| Other | 1.050 | 0.786–1.404 | 0.741 | |||
| Grade | ||||||
| I | Ref | Ref | ||||
| II | 1.192 | 0.847–1.678 | 0.313 | 1.207 | 0.893–1.632 | 0.220 |
| III | 1.407 | 1.014–1.953 | 0.041* | 1.156 | 0.862–1.550 | 0.334 |
| IV | 1.342 | 0.961–1.874 | 0.085 | 1.214 | 0.895–1.646 | 0.213 |
| Histology | ||||||
| SCC | Ref | |||||
| TCC | 1.122 | 0.957–1.314 | 0.155 | 0.899 | 0.749–1.079 | 0.251 |
| AC | 0.906 | 0.737–1.114 | 0.301 | 0.765 | 0.619–0.946 | 0.014* |
| Other | 1.289 | 1.037–1.601 | 0.022* | 0.898 | 0.717–1.126 | 0.352 |
| T stage | ||||||
| T0/T1 | Ref | Ref | ||||
| T2 | 1.105 | 0.913–1.337 | 0.307 | 1.125 | 0.773–1.636 | 0.539 |
| T3 | 1.577 | 1.313–1.894 | <0.001* | 1.444 | 1.059–1.969 | 0.020* |
| T4 | 2.144 | 1.738–2.646 | <0.001* | 1.788 | 1.273–2.512 | <0.001* |
| N stage | ||||||
| N0 | Ref | Ref | ||||
| N1 | 1.530 | 1.239–1.891 | <0.001* | 1.057 | 0.837–1.333 | 0.643 |
| N2 | 1.810 | 1.464–2.238 | <0.001* | 1.413 | 1.073–1.862 | 0.014* |
| M stage of BC | ||||||
| M0 | Ref | Ref | ||||
| M1 | 4.646 | 3.845–5.615 | <0.001* | 3.080 | 2.377–3.990 | <0.001* |
| AJCC stage groups | ||||||
| I | Ref | Ref | ||||
| II | 1.075 | 0.859–1.345 | 0.528 | 1.015 | 0.661–1.558 | 0.947 |
| III | 1.271 | 1.030–1.570 | 0.026* | 1.037 | 0.722–1.490 | 0.843 |
| IV | 2.685 | 2.247–3.209 | <0.001* | 0.973 | 0.658–1.438 | 0.891 |
| Tumor size, mm | ||||||
| <30 | Ref | Ref | ||||
| ≥ 30 | 1.662 | 1.307–2.115 | <0.001* | 1.369 | 1.176–1.594 | <0.001* |
| Surgery | ||||||
| No surgery | Ref | Ref | ||||
| Local therapy | 0.599 | 0.511–0.701 | <0.001* | 0.832 | 0.700–0.989 | 0.037* |
| Radical therapy | 0.458 | 0.389–0.539 | <0.001* | 0.626 | 0.524–0.746 | <0.001* |
| Radiation | ||||||
| No/Unknown | Ref | |||||
| Yes | 1.003 | 0.866–1.162 | 0.966 | |||
| Chemotherapy | ||||||
| No/Unknown | Ref | |||||
| Yes | 0.984 | 0.855–1.134 | 0.826 | |||
OS Overall survival, PUC Primary urethral carcinoma, HR Hazard ratio, CI Confidence interval, Ref Reference, AJCC American Joint Committee on Cancer
Grade: Grade I (Well differentiated); Grade II (Moderately differentiated); Grade III (Poorly differentiated); Grade IV (Undifferentiated)